• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性传播感染(梅毒、淋病、衣原体和单纯疱疹)治疗中的迷人分子和免疫逃逸机制。

Fascinating Molecular and Immune Escape Mechanisms in the Treatment of STIs (Syphilis, Gonorrhea, Chlamydia, and Herpes Simplex).

机构信息

Department of Dermatology I, Colentina Clinical Hospital, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020125 Bucharest, Romania.

Department of Urology, Clinical Hospital Prof. Dr. Th. Burghele, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 030167 Bucharest, Romania.

出版信息

Int J Mol Sci. 2022 Mar 24;23(7):3550. doi: 10.3390/ijms23073550.

DOI:10.3390/ijms23073550
PMID:35408911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8998805/
Abstract

The incidence of syphilis, gonorrhea, chlamydia, and herpes simplex has increased over the last decade, despite the numerous prevention strategies. Worldwide scientists report a surge in drug-resistant infections, particularly in immunocompromised patients. Antigenic variations in syphilis enable long-term infection, but benzathine penicillin G maintains its efficiency, whereas macrolides should be recommended with caution. Mupirocin and zoliflodacin were recently introduced as therapies against ceftriaxone-resistant gonococcus, which poses a larger global threat. The gastrointestinal and prostatic potential reservoirs of Chlamydia trachomatis may represent the key towards complete eradication. Similar to syphilis, macrolides resistance has to be considered in genital chlamydiosis. Acyclovir-resistant HSV may respond to the novel helicase-primase inhibitors and topical imiquimod, particularly in HIV-positive patients. Novel drugs can overcome these challenges while nanocarriers enhance their potency, particularly in mucosal areas. This review summarizes the most recent and valuable discoveries regarding the immunopathogenic mechanisms of these sexually transmitted infections and discusses the challenges and opportunities of the novel molecules and nanomaterials.

摘要

尽管采取了众多预防策略,但在过去十年中,梅毒、淋病、衣原体和单纯疱疹的发病率有所上升。全球科学家报告称,耐药感染病例激增,尤其是在免疫功能低下的患者中。梅毒的抗原变异使其能够长期感染,但苄星青霉素 G 仍保持其疗效,而大环内酯类药物的使用应谨慎。莫匹罗星和唑利福定最近被引入作为治疗对头孢曲松耐药淋病奈瑟菌的疗法,这对全球构成了更大的威胁。沙眼衣原体在胃肠道和前列腺的潜在储库可能是实现完全根除的关键。与梅毒一样,在生殖器衣原体病中也需要考虑大环内酯类药物的耐药性。新型疱疹病毒可能对新型解旋酶-引物抑制剂和局部咪喹莫特有反应,尤其是在 HIV 阳性患者中。新型药物可以克服这些挑战,而纳米载体则可以增强其效力,特别是在黏膜区域。本综述总结了关于这些性传播感染的免疫发病机制的最新和最有价值的发现,并讨论了新型分子和纳米材料的挑战和机遇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/ce41849eb04d/ijms-23-03550-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/c15bd151a8b5/ijms-23-03550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/12d48bbdabc1/ijms-23-03550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/13d3f8001322/ijms-23-03550-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/ce41849eb04d/ijms-23-03550-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/c15bd151a8b5/ijms-23-03550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/12d48bbdabc1/ijms-23-03550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/13d3f8001322/ijms-23-03550-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/8998805/ce41849eb04d/ijms-23-03550-g004.jpg

相似文献

1
Fascinating Molecular and Immune Escape Mechanisms in the Treatment of STIs (Syphilis, Gonorrhea, Chlamydia, and Herpes Simplex).性传播感染(梅毒、淋病、衣原体和单纯疱疹)治疗中的迷人分子和免疫逃逸机制。
Int J Mol Sci. 2022 Mar 24;23(7):3550. doi: 10.3390/ijms23073550.
2
Diagnosis and Treatment of Sexually Transmitted Infections: A Review.性传播感染的诊断与治疗:综述
JAMA. 2022 Jan 11;327(2):161-172. doi: 10.1001/jama.2021.23487.
3
Increasing incidence rates of sexually transmitted infections from 2010 to 2019: an analysis of temporal trends by geographical regions and age groups from the 2019 Global Burden of Disease Study.2010 年至 2019 年性传播感染发病率上升:基于 2019 年全球疾病负担研究的地理区域和年龄组时间趋势分析。
BMC Infect Dis. 2022 Jun 26;22(1):574. doi: 10.1186/s12879-022-07544-7.
4
Sexually transmitted infections among active component members of the U.S. Armed Forces, 2015-2023.美国武装部队现役成员中的性传播感染,2015-2023 年。
MSMR. 2024 Jun 20;31(6):34-42.
5
Changing Demography of Genital Chlamydia, Gonorrhea, Genital Herpes, Condyloma, and Syphilis Infections in Japan.日本生殖器衣原体、淋病、生殖器疱疹、尖锐湿疣和梅毒感染人口统计学变化。
Jpn J Infect Dis. 2021 Jan 22;74(1):35-41. doi: 10.7883/yoken.JJID.2020.005. Epub 2020 Jun 30.
6
Sexually transmitted diseases other than human immunodeficiency virus infection in older adults.老年人中除人类免疫缺陷病毒感染以外的性传播疾病
Clin Infect Dis. 2003 Mar 1;36(5):609-14. doi: 10.1086/367892. Epub 2003 Feb 17.
7
Update: Sexually transmitted infections, active component, U.S. Armed Forces, 2013-2021.更新:2013-2021 年美国武装部队性传播感染活跃成分。
MSMR. 2022 May 1;29(5):2-11.
8
Trends in sexually transmitted diseases and condom use patterns among commercial sex workers in Fukuoka City, Japan 1990-93.1990 - 1993年日本福冈市商业性工作者的性传播疾病趋势及避孕套使用模式
Genitourin Med. 1996 Oct;72(5):358-61. doi: 10.1136/sti.72.5.358.
9
Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa.南非初级保健诊所就诊的生殖器溃疡综合征男性中生殖器溃疡和尿道病原体的流行情况及相关性。
Sex Transm Dis. 2012 Nov;39(11):880-5. doi: 10.1097/OLQ.0b013e318269cf90.
10
Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.多伦多男男性行为者中艾滋病毒阳性和阴性者的性传播病毒和细菌感染患病率
PLoS One. 2016 Jul 8;11(7):e0158090. doi: 10.1371/journal.pone.0158090. eCollection 2016.

引用本文的文献

1
Research advances in immune agonists and their nanoparticles for enhancing the immunotherapeutic efficacy of PD-1 inhibitors in malignancies.免疫激动剂及其纳米颗粒在提高PD-1抑制剂治疗恶性肿瘤免疫疗效方面的研究进展
Front Oncol. 2025 Aug 26;15:1618903. doi: 10.3389/fonc.2025.1618903. eCollection 2025.
2
The Significance of the Cell-Mediated Host Immune Response in Syphilis.细胞介导的宿主免疫反应在梅毒中的意义。
Microorganisms. 2024 Dec 13;12(12):2580. doi: 10.3390/microorganisms12122580.
3
Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines.

本文引用的文献

1
Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.厄他培南、庆大霉素、磷霉素和头孢曲松治疗肛门生殖器淋病的疗效(NABOGO):一项随机非劣效性试验。
Lancet Infect Dis. 2022 May;22(5):706-717. doi: 10.1016/S1473-3099(21)00625-3. Epub 2022 Jan 19.
2
The Peptide A-3302-B Isolated from a Marine Bacterium sp. Inhibits HSV-2 Infection by Preventing the Viral Egress from Host Cells.从海洋细菌 sp. 中分离得到的肽 A-3302-B 通过阻止病毒从宿主细胞逸出抑制 HSV-2 感染。
Int J Mol Sci. 2022 Jan 15;23(2):947. doi: 10.3390/ijms23020947.
3
女性生殖道性传播细菌感染的免疫:迈向有效的疫苗
Vaccines (Basel). 2024 Aug 1;12(8):863. doi: 10.3390/vaccines12080863.
4
Squamous Cell Carcinoma In Situ-The Importance of Early Diagnosis in Bowen Disease, Vulvar Intraepithelial Neoplasia, Penile Intraepithelial Neoplasia, and Erythroplasia of Queyrat.原位鳞状细胞癌——鲍温病、外阴上皮内瘤变、阴茎上皮内瘤变及凯腊增殖性红斑早期诊断的重要性
Diagnostics (Basel). 2024 Aug 16;14(16):1799. doi: 10.3390/diagnostics14161799.
5
Cutaneous Eruption in a Crohn's Disease Patient Under Tumor Necrosis Alpha Inhibitor Treatment: A Rare Case of Syphilis.一名接受肿瘤坏死因子α抑制剂治疗的克罗恩病患者出现皮肤疹:一例罕见的梅毒病例
Cureus. 2024 Mar 26;16(3):e57003. doi: 10.7759/cureus.57003. eCollection 2024 Mar.
6
When Bacteria and Viruses Collide: A Tale of and Sexually Transmitted Viruses.当细菌和病毒碰撞时:一个关于 和性传播病毒的故事。
Viruses. 2023 Sep 19;15(9):1954. doi: 10.3390/v15091954.
7
Unveiling the stealthy tactics: mycoplasma's immune evasion strategies.揭示支原体的隐匿战术:免疫逃避策略。
Front Cell Infect Microbiol. 2023 Aug 31;13:1247182. doi: 10.3389/fcimb.2023.1247182. eCollection 2023.
8
Chlamydial and Gonococcal Genital Infections: A Narrative Review.衣原体和淋球菌性生殖器感染:一篇叙述性综述。
J Pers Med. 2023 Jul 21;13(7):1170. doi: 10.3390/jpm13071170.
9
Therapeutic Options for Infection: Present and Future.感染的治疗选择:现状与未来
Antibiotics (Basel). 2022 Nov 16;11(11):1634. doi: 10.3390/antibiotics11111634.
Acyclovir-resistant chronic mucocutaneous herpes with good response to the association with imiquimod in an AIDS patient: case report.
一名艾滋病患者对阿昔洛韦耐药的慢性黏膜皮肤疱疹,联用咪喹莫特后反应良好:病例报告
An Bras Dermatol. 2022 Mar-Apr;97(2):264-266. doi: 10.1016/j.abd.2020.10.019. Epub 2022 Jan 14.
4
Dynamics of the Catalytic Active Site of Isoleucyl tRNA Synthetase from bound with Adenylate and Mupirocin.结合腺嘌呤和莫匹罗星的异亮氨酰 tRNA 合成酶催化活性位点的动态。
J Phys Chem B. 2022 Jan 27;126(3):620-633. doi: 10.1021/acs.jpcb.1c08555. Epub 2022 Jan 11.
5
Dissemination and genome analysis of high-level ceftriaxone-resistant 60.001 strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019.2016-2019 年广东省淋球菌耐药监测项目(GD-GASP)中高水平头孢曲松耐药 60.001 株的传播和基因组分析。
Emerg Microbes Infect. 2022 Dec;11(1):344-350. doi: 10.1080/22221751.2021.2011618.
6
Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018.2015 年至 2018 年期间,由于 NG-MAST 12302 克隆传播,加拿大淋病奈瑟菌对阿奇霉素的耐药性不断增加。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0168821. doi: 10.1128/AAC.01688-21. Epub 2022 Jan 3.
7
Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria.可注射纳米莫匹罗星脂质体对多重耐药菌感染的治疗潜力
Pharmaceutics. 2021 Dec 17;13(12):2186. doi: 10.3390/pharmaceutics13122186.
8
Soluble Factors and Receptors Involved in Skin Innate Immunity-What Do We Know So Far?皮肤固有免疫中涉及的可溶性因子和受体——我们目前了解多少?
Biomedicines. 2021 Nov 29;9(12):1795. doi: 10.3390/biomedicines9121795.
9
Chlamydia trachomatis induces lncRNA MIAT upregulation to regulate mitochondria-mediated host cell apoptosis and chlamydial development.沙眼衣原体诱导长链非编码 RNA MIAT 上调,以调节线粒体介导的宿主细胞凋亡和衣原体发育。
J Cell Mol Med. 2022 Jan;26(1):163-177. doi: 10.1111/jcmm.17069. Epub 2021 Dec 3.
10
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines.直肠衣原体感染:对再感染风险、筛查及治疗指南的影响
Curr Opin Infect Dis. 2022 Feb 1;35(1):42-48. doi: 10.1097/QCO.0000000000000804.